Exact Mass: 302.171

Exact Mass Matches: 302.171

Found 159 metabolites which its exact mass value is equals to given mass value 302.171, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glycerol tributanoate

1,3-bis(butanoyloxy)propan-2-yl butanoate

C15H26O6 (302.1729)


Flavouring agent. Glycerol tributanoate is found in many foods, some of which are durian, canola, conch, and italian sweet red pepper. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Glycerol tributanoate is a flavouring agent

   

Farnesyl phosphate

trans,trans-Farnesyl phosphate

C15H27O4P (302.1647)


   

Arginylglutamine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702)


Arginylglutamine is a dipeptide composed of arginine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylarginine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-5-carbamimidamidopentanoate

C11H22N6O4 (302.1702)


Glutaminylarginine is a dipeptide composed of glutamine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginyl-Gamma-glutamate

2-Amino-4-[(2-amino-5-carbamimidamidopentanoyl)-C-hydroxycarbonimidoyl]butanoate

C11H22N6O4 (302.1702)


Arginyl-Gamma-glutamate is a dipeptide composed of arginine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

DL-Valine-4-antipyrineamide

2-Amino-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methylbutanimidate

C16H22N4O2 (302.1743)


   

Emivirine

6-benzyl-1-(ethoxymethyl)-5-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

C17H22N2O3 (302.163)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

1,1,1-Tri(butyryloxy)propane

1,1-Bis(butanoyloxy)propyl butanoic acid

C15H26O6 (302.1729)


   

tributyrylglycerol

5-butanoyl-5,6-dihydroxy-6-(hydroxymethyl)decane-4,7-dione

C15H26O6 (302.1729)


   

trichostatin A

N-Hydroxy7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidate

C17H22N2O3 (302.163)


   

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

N-Hydroxy7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-3,5-dienimidate

C17H22N2O3 (302.163)


   

13-Acetoxyanagyrine

13-Acetoxyanagyrine

C17H22N2O3 (302.163)


   
   
   

2,4-Bis(1-phenylethyl)phenol

2,4-Bis(1-phenylethyl)phenol

C22H22O (302.1671)


   
   
   
   

Trichostatin A S-isomer

Trichostatin A S-isomer

C17H22N2O3 (302.163)


   

3-isobutyrylamino-1-phenethyl-piperidine-2,6-dione

3-isobutyrylamino-1-phenethyl-piperidine-2,6-dione

C17H22N2O3 (302.163)


   

rosiridoside A

rosiridoside A

C15H26O6 (302.1729)


   
   

2,6-bis(1-phenylethyl)phenol

2,6-bis(1-phenylethyl)phenol

C22H22O (302.1671)


   

leptoclinidamide trifluoroacetic acid salt

leptoclinidamide trifluoroacetic acid salt

C16H22N4O2 (302.1743)


   

deschloro 12-epi-fischerindole I nitrile

deschloro 12-epi-fischerindole I nitrile

C21H22N2 (302.1783)


   

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

C15H26O6 (302.1729)


   

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   

4-Dimethylamino-tritylamin|4-dimethylamino-tritylamine|alpha-Amino-4-dimethylamino-triphenylmethan

4-Dimethylamino-tritylamin|4-dimethylamino-tritylamine|alpha-Amino-4-dimethylamino-triphenylmethan

C21H22N2 (302.1783)


   
   

alanylglycylarginine

alanylglycylarginine

C11H22N6O4 (302.1702)


   
   

glycylalanylarginine

glycylalanylarginine

C11H22N6O4 (302.1702)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1743)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

C16H22N4O2 (302.1743)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

C16H22N4O2 (302.1743)


   

Tributyrin (C4:0)

Tributyrin (C4:0)

C15H26O6 (302.1729)


   

butyrin

Glyceryl tributyrate

C15H26O6 (302.1729)


A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by butyric acid. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer

   

Ergoline-1,8-dimethanol, 10-methoxy-, (8b)-

Ergoline-1,8-dimethanol, 10-methoxy-, (8b)-

C17H22N2O3 (302.163)


   
   
   
   
   
   
   

Trichostatin A

7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6R-dimethyl-7-oxo-2E,4E-heptadienamide

C17H22N2O3 (302.163)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC[1].

   

α-hydroxy Farnesyl Phosphonic Acid

(±)-1-hydroxy-3,7,11-trimethyl-2E,6E,10-dodecatriene-1-phosphonic acid

C15H27O4P (302.1647)


   

Arg-GLN

2-(2-amino-4-carbamoylbutanamido)-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702)


A dipeptide formed from L-arginyl and L-glutamine residues.

   

Arg-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702)


   

GLN-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702)


   

GGlu-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H22N6O4 (302.1702)


   

FOH 22:12

(4Z,19Z)-docosa-4,19-diene-2,9,11,13,21-pentayne-1-ol

C22H22O (302.1671)


   

ascr#3

8R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-2E-nonenoic acid

C15H26O6 (302.1729)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,8R)-8-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#2, ascr#4, and ascr#8 in male attraction.

   

oscr#3

9-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-nonenoic acid

C15H26O6 (302.1729)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-9-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   
   

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

1-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4-piperidine]

1-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4-piperidine]

C17H22N2O3 (302.163)


   

Nortriptyline-d3 hydrochloride

Nortriptyline-d3 hydrochloride

C19H19ClD3N (302.1629)


   

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

C16H22N4O2 (302.1743)


   
   

2-({2,2-Bis[(oxiran-2-ylmethoxy)methyl]butoxy}methyl)oxirane

1-(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane

C15H26O6 (302.1729)


   

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

C15H26O6 (302.1729)


   

3-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-methyl-1h-indole

3-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-methyl-1h-indole

C21H22N2 (302.1783)


   

(S)-BENZYL 2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBOXYLATE

(S)-BENZYL 2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBOXYLATE

C17H22N2O3 (302.163)


   

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N4O2 (302.1743)


   

Propranolol D7 hydrochloride

Propranolol D7 hydrochloride

C16H15D7ClNO2 (302.1778)


   

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

Benzyl 4-(2-oxopyrrolidin-1-yl)piperidine-1-carboxylate

Benzyl 4-(2-oxopyrrolidin-1-yl)piperidine-1-carboxylate

C17H22N2O3 (302.163)


   

pyrrolidin-1-yl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]methanone

pyrrolidin-1-yl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]methanone

C16H23BN2O3 (302.1802)


   

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

C22H22O (302.1671)


   

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

C16H22N4O2 (302.1743)


   

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

C15H26O6 (302.1729)


   

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

1-Cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

1-Cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

C16H23BN2O3 (302.1802)


   

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

C15H26O6 (302.1729)


   

3-[(2S)-2-[3-(cyclopropylmethoxy)-4-methoxyphenyl]propyl]-1H-imidazol-2-one

3-[(2S)-2-[3-(cyclopropylmethoxy)-4-methoxyphenyl]propyl]-1H-imidazol-2-one

C17H22N2O3 (302.163)


   

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1743)


   

aluminum di(sec-butoxide)acetoacetic ester chelate

aluminum di(sec-butoxide)acetoacetic ester chelate

C14H27AlO5 (302.1674)


   

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

C14H18N4.C2H4O2 (302.1743)


   

tert-butyl (1r,3r)-1-(4-cyanophenyl)-3-hydroxy-3-MethylcyclobutylcarbaMate

tert-butyl (1r,3r)-1-(4-cyanophenyl)-3-hydroxy-3-MethylcyclobutylcarbaMate

C17H22N2O3 (302.163)


   

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

C11H22N6O4 (302.1702)


   

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689)


   

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689)


   

(R)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate

(R)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate

C17H22N2O3 (302.163)


   
   

7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide

7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide

C17H22N2O3 (302.163)


   

N-(4-morpholinobutyl)benzofuran-2-carboxamide

N-(4-morpholinobutyl)benzofuran-2-carboxamide

C17H22N2O3 (302.163)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

C15H26O6 (302.1729)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1743)


   

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

C11H22N6O4 (302.1702)


   
   

N-(N2-L-Alanyl-L-arginyl)glycine

N-(N2-L-Alanyl-L-arginyl)glycine

C11H22N6O4 (302.1702)


   

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

C11H22N6O4 (302.1702)


   

Emivirine

Emivirine

C17H22N2O3 (302.163)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

12-epi-fischerindole I

12-epi-fischerindole I

C21H22N2 (302.1783)


   
   

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-3,5-dienamide

C17H22N2O3 (302.163)


   

N-cyclohexyl-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide

N-cyclohexyl-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide

C17H22N2O3 (302.163)


   

Rosanilin(1+)

Rosanilin(1+)

C20H20N3+ (302.1657)


   

N-(5-tert-butyl-2-methoxyphenyl)-3,5-dimethyl-4-isoxazolecarboxamide

N-(5-tert-butyl-2-methoxyphenyl)-3,5-dimethyl-4-isoxazolecarboxamide

C17H22N2O3 (302.163)


   

3-[(3,3-dimethyl-1-oxobutyl)amino]-1H-indole-2-carboxylic acid ethyl ester

3-[(3,3-dimethyl-1-oxobutyl)amino]-1H-indole-2-carboxylic acid ethyl ester

C17H22N2O3 (302.163)


   
   

1-[2-[2-(2-Methoxy-6-prop-2-enylphenoxy)ethoxy]ethyl]imidazole

1-[2-[2-(2-Methoxy-6-prop-2-enylphenoxy)ethoxy]ethyl]imidazole

C17H22N2O3 (302.163)


   
   
   

[(1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl dihydrogen phosphate

[(1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl dihydrogen phosphate

C15H27O4P (302.1647)


   

2,6-DI(alpha-Methylbenzyl(5D))phenol

2,6-DI(alpha-Methylbenzyl(5D))phenol

C22H22O (302.1671)


   

Arginyl-glutamine

Arginyl-glutamine

C11H22N6O4 (302.1702)


   

Glutaminyl-arginine

Glutaminyl-arginine

C11H22N6O4 (302.1702)


   

Arginyl-Gamma-glutamate

Arginyl-Gamma-glutamate

C11H22N6O4 (302.1702)


   

ascaroside C9

ascaroside C9

C15H26O6 (302.1729)


   

glutaminylarginine

glutaminylarginine

C11H22N6O4 (302.1702)


   

(2E,6E)-farnesyl monophosphate

(2E,6E)-farnesyl monophosphate

C15H27O4P (302.1647)


A member of the class of farnesyl phosphates that is the monophosphatr derivative of (2E,6E)-farnesol

   
   

TG 4:0/4:0/4:0

TG 4:0/4:0/4:0

C15H26O6 (302.1729)


   
   
   

RO-3

RO-3

C16H22N4O2 (302.1743)


RO-3 is a potent, CNS-penetrant, and orally active P2X3 and P2X2/3 antagonist with pIC50s of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. RO-3 shows selectivity for P2X3 and P2X2/3 over all other functional homomultimeric P2X receptors (IC50 >10?μM at P2X1,2,4,5,7)[1].

   

(1s,2r,4r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

(1s,2r,4r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

(6as,9s)-9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

(6as,9s)-9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

C21H22N2 (302.1783)


   

9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

C21H22N2 (302.1783)


   

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

C15H26O6 (302.1729)


   

n-[(3s)-2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

n-[(3s)-2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

C17H22N2O3 (302.163)


   

6-benzyl-3-isopropyl-1,4-dimethyl-1,4-diazepane-2,5,7-trione

6-benzyl-3-isopropyl-1,4-dimethyl-1,4-diazepane-2,5,7-trione

C17H22N2O3 (302.163)


   

(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

13-o-acetylbaptifoline

NA

C17H22N2O3 (302.163)


{"Ingredient_id": "HBIN001269","Ingredient_name": "13-o-acetylbaptifoline","Alias": "NA","Ingredient_formula": "C17H22N2O3","Ingredient_Smile": "CC(=O)OC1CCN2CC3CC(C2C1)CN4C3=CC=CC4=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "329","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acanthoine

NA

C16H22N4O2 (302.1743)


{"Ingredient_id": "HBIN014343","Ingredient_name": "acanthoine","Alias": "NA","Ingredient_formula": "C16H22N4O2","Ingredient_Smile": "COC1=C(C=C(C=C1)C=CC(C=CCN=CN)N=CN)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "81","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-hydroxy-2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

2-hydroxy-2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

C17H22N2O3 (302.163)


   

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

C22H22O (302.1671)


   

(1r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

(1r,9s)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

(2e,4e,6r)-6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

(2e,4e,6r)-6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   

n-hydroxy(2e,4e)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

n-hydroxy(2e,4e)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

C16H22N4O2 (302.1743)


   

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

C15H26O6 (302.1729)


   

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

C22H22O (302.1671)


   

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729)


   

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

C16H22N4O2 (302.1743)


   

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-10,12-dien-4-yl acetate

C17H22N2O3 (302.163)


   

7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

7-[4-(dimethylamino)phenyl]-6-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729)


   

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

C16H22N4O2 (302.1743)


   

2-hydroxy-2-methyl-n-{1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl}propanimidic acid

2-hydroxy-2-methyl-n-{1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl}propanimidic acid

C17H22N2O3 (302.163)


   

2,4-bis[(1r)-1-phenylethyl]phenol

2,4-bis[(1r)-1-phenylethyl]phenol

C22H22O (302.1671)


   

6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

6-hydroxy-n,4,6-trimethyl-7-[4-(methylamino)phenyl]-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

n-(2-{3-[(1-hydroxyethylidene)amino]propanoyl}phenyl)-2,2-dimethylbut-3-enimidic acid

n-(2-{3-[(1-hydroxyethylidene)amino]propanoyl}phenyl)-2,2-dimethylbut-3-enimidic acid

C17H22N2O3 (302.163)


   

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

C15H26O6 (302.1729)


   

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

C16H22N4O2 (302.1743)


   

n-[2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

n-[2,6-dioxo-1-(2-phenylethyl)piperidin-3-yl]-2-methylpropanimidic acid

C17H22N2O3 (302.163)


   

n-hydroxy(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

n-hydroxy(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidic acid

C17H22N2O3 (302.163)


   

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1671)


   

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729)